Translational Regulation of X-Linked Inhibitor of Apoptosis Protein by Interleukin-6: A Novel Mechanism of Tumor Cell Survival

Yoko Yamagiwa, Carla Marienfeld, Fanyin Meng, Martin Holcik, Tushar Patel

Research output: Contribution to journalArticle

55 Scopus citations

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine with diverse biological effects. IL-6 has been implicated in autocrine signaling pathways promoting tumor progression and chemoresistance in some human tumors. However, the mechanisms by which IL-6 modulates these responses are unknown. Aberrant apoptosis has been implicated as a fundamental mechanism of chemotherapeutic resistance. Thus, we investigated whether IL-6 alters the expression of apoptosis regulatory proteins as a mechanism of drug resistance. We provide evidence that IL-6 rapidly phosphorylates the translation initiation factor eukaryotic initiation factor-4E and triggers antiapoptotic responses in cholangiocarcinoma cells. Reduction of cellular eukaryotic initiation factor-4E by RNA interference decreases IL-6-induced effects on cytotoxic drug-induced caspase activation and apoptosis. Furthermore, IL-6 increases expression of the endogenous X-linked inhibitor of apoptosis protein expression by translation at an internal ribosome entry site. Our findings that IL-6 translationally regulates X-linked inhibitor of apoptosis protein expression reveal a novel mechanism by which IL-6 mediates tumor cell survival that may be targeted therapeutically to decrease tumor progression and chemoresistance.

Original languageEnglish (US)
Pages (from-to)1293-1298
Number of pages6
JournalCancer research
Volume64
Issue number4
DOIs
StatePublished - Feb 15 2004
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Translational Regulation of X-Linked Inhibitor of Apoptosis Protein by Interleukin-6: A Novel Mechanism of Tumor Cell Survival'. Together they form a unique fingerprint.

  • Cite this